Literature DB >> 1596687

Adenosine receptors in post-mortem human brain.

S James1, J H Xuereb, R Askalan, P J Richardson.   

Abstract

1. Adenosine A2-like binding sites were characterized in post-mortem human brain membranes by examining several compounds for their ability to displace [3H]-CGS 21680 (2[p-(2 carboxyethyl)-phenethylamino]-5'-N-ethylcarboxamido adenosine) binding. 2. Two A2-like binding sites were identified in the striatum. 3. The more abundant striatal site was similar to the A2a receptor previously described in rat striatum, both in its pharmacological profile and striatal localization. 4. The less abundant striatal site had a pharmacological profile similar to that of the binding site characterized in the other brain regions examined. This was intermediate in character between A1 and A2 and may represent another adenosine receptor subtype. 5. The co-purification of [3H]-CGS 21680 binding during immunoisolation of human striatal cholinergic membranes was used to assess the possible cholinergic localization of A2-like binding sites in the human striatum. Only the more abundant striatal site co-purified with cholinergic membranes. This suggests that this A2a-like site is present on cholinergic neurones in the human striatum.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1596687      PMCID: PMC1908630          DOI: 10.1111/j.1476-5381.1992.tb14240.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  A new and rapid colorimetric determination of acetylcholinesterase activity.

Authors:  G L ELLMAN; K D COURTNEY; V ANDRES; R M FEATHER-STONE
Journal:  Biochem Pharmacol       Date:  1961-07       Impact factor: 5.858

2.  The properties and extracellular location of 5'-nucleotidase of the rat fat-cell plasma membrane.

Authors:  A C Newby; J P Luzio; C N Hales
Journal:  Biochem J       Date:  1975-03       Impact factor: 3.857

3.  Adenosine receptor agonists inhibit inositol phosphate accumulation in rat striatal slices.

Authors:  D W Petcoff; D M Cooper
Journal:  Eur J Pharmacol       Date:  1987-06-04       Impact factor: 4.432

Review 4.  The physiological role of adenosine in the central nervous system.

Authors:  T V Dunwiddie
Journal:  Int Rev Neurobiol       Date:  1985       Impact factor: 3.230

5.  Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.

Authors:  R F Bruns; G H Lu; T A Pugsley
Journal:  Mol Pharmacol       Date:  1986-04       Impact factor: 4.436

6.  Confirmation of the cholinergic specificity of the Chol-1 gangliosides in mammalian brain using affinity-purified antisera and lesions affecting the cholinergic input to the hippocampus.

Authors:  E A Derrington; D Masco; V P Whittaker
Journal:  J Neurochem       Date:  1989-12       Impact factor: 5.372

7.  [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.

Authors:  M F Jarvis; R Schulz; A J Hutchison; U H Do; M A Sills; M Williams
Journal:  J Pharmacol Exp Ther       Date:  1989-12       Impact factor: 4.030

8.  The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis.

Authors:  C Nanoff; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1991-02       Impact factor: 4.436

9.  Adenosine receptors in post-mortem human cerebral cortex and the effect of carbamazepine.

Authors:  P R Dodd; W E Watson; G A Johnston
Journal:  Clin Exp Pharmacol Physiol       Date:  1986-10       Impact factor: 2.557

10.  Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease.

Authors:  M I Martinez-Mir; A Probst; J M Palacios
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

View more
  8 in total

1.  Characterization of adenosine receptors in brush-border membranes from pig kidney.

Authors:  J Blanco; E I Canela; J Mallol; C Lluís; R Franco
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

2.  Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.

Authors:  R A Cunha; B Johansson; M D Constantino; A M Sebastião; B B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

3.  Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices.

Authors:  S Latini; F Bordoni; R Corradetti; G Pepeu; F Pedata
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

4.  Adenosine A2 receptor regulation of apomorphine-induced turning in rats with unilateral striatal dopamine denervation.

Authors:  S V Vellucci; D J Sirinathsinghji; P J Richardson
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Adenosine receptor-mediated modulation of acetylcholine release from rat striatal synaptosomes.

Authors:  K A Kirkpatrick; P J Richardson
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

6.  Binding of the prototypical adenosine A(2A) receptor agonist CGS 21680 to the cerebral cortex of adenosine A(1) and A(2A) receptor knockout mice.

Authors:  Luísa V Lopes; Linda Halldner; Nelson Rebola; Björn Johansson; Catherine Ledent; Jian Fan Chen; Bertil B Fredholm; Rodrigo A Cunha
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

7.  Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release.

Authors:  M Kurokawa; I P Kirk; K A Kirkpatrick; H Kase; P J Richardson
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

8.  Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex.

Authors:  I P Kirk; P J Richardson
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.